Reply to Yoshioka et al

Dong Ji¹, Enqiang Qin¹, Dawei Zhang¹, Gregory Cheng², George Lau^{1

2}

Affiliations

¹ Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
² Humanity and Health Clinical Trial Center, Humanity and Health Medical Group, Hong Kong, China.

Editorial

Dong Ji et al. Clin Infect Dis. 2021.

. 2021 Nov 2;73(9):e2819.

doi: 10.1093/cid/ciaa1568.

Dong Ji¹, Enqiang Qin¹, Dawei Zhang¹, Gregory Cheng², George Lau^{1

2}

¹ Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
² Humanity and Health Clinical Trial Center, Humanity and Health Medical Group, Hong Kong, China.

No abstract available

Comment on

Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.
Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, Chen G, Cheng G, Wang Y, Bi J, Tan L, Lau G, Qin E. Ji D, et al. Clin Infect Dis. 2020 Sep 12;71(6):1393-1399. doi: 10.1093/cid/ciaa414. Clin Infect Dis. 2020. PMID: 32271369 Free PMC article.
The Inherent Problems With the Generalizability of the CALL Score: Towards Reliable Clinical Prediction Models for Coronavirus Disease 2019 (COVID-19).
Yoshioka T, Funada S, Luo Y. Yoshioka T, et al. Clin Infect Dis. 2021 Nov 2;73(9):e2818. doi: 10.1093/cid/ciaa1564. Clin Infect Dis. 2021. PMID: 33064127 Free PMC article. No abstract available.